PlainRecalls
FDA Drug Low Class III Terminated

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Reported: October 15, 2014 Initiated: September 30, 2014 #D-0013-2015

Product Description

Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1

Reason for Recall

Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

Details

Recalling Firm
Gilead Sciences, Inc.
Units Affected
10,317 bottles
Distribution
Nationwide
Location
Foster City, CA

Frequently Asked Questions

What product was recalled?
Truvada (200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate) tablets, 30 count bottles, Rx only, Manufactured for Gilead Sciences, Inc. Foster City, CA 94404, NDC 61958-0701-1. Recalled by Gilead Sciences, Inc.. Units affected: 10,317 bottles.
Why was this product recalled?
Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 15, 2014. Severity: Low. Recall number: D-0013-2015.